Synopsis of recent research by authors named "Alberto Zambon"
Alberto Zambon's recent research primarily focuses on the treatment and management of dyslipidemia, particularly in patients with familial hypercholesterolemia, as seen in studies on lomitapide and PCSK9 inhibitors, emphasizing efficacy and patient outcomes within clinical settings.
His studies also highlight the importance of medication adherence among patients using combination therapies, such as rosuvastatin/ezetimibe, illustrating the impact of pill burden on patient compliance and health economics.
Furthermore, Zambon explores the interplay between genetic disorders and neuromuscular diseases, advocating for a better understanding of molecular mechanisms to inform therapeutic strategies and enhance patient care.
